What this trial means for you
This study is by invitation only. It is not currently taking new participants, but its results may matter for treatments you're considering. It's studying GLP-1, Placebo for longevity, quality of life, mood.
What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study, ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.
The study, in the sponsor's words
The goal of this clinical study has two objectives. The Primary Objective is to evaluate the effectiveness of microdosed GLP-1 receptor agonists in improving measures of health, quality of life, and longevity. The Secondary Objective: To assess the impact of these therapies on weight management practices and metabolic health.
Can you join? The exact criteria
Below is the verbatim eligibility text from the registry. Bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.
Full eligibility criteria (for you and your doctor)
Inclusion Criteria: * New or existing AgelessRx patient * Adults (aged 18-65) * Any sex * Any ethnicity * BMI ≥ 20 kg/m\^2 * Interest in taking microdoses of semaglutide for health and longevity improvement with no intent to seek weight loss improvement. Exclusion Criteria: * Individuals who are denied a longevity product by the AgelessRx medical team will not be asked to participate in any product specific test(s) or questionnaire(s) * History of bariatric surgery * Use of other weight-loss medications currently or within the past 6 months * Contraindications to semaglutide * Significant psychiatric illness that may affect participation * Pregnant or breastfeeding individuals
Study sites by state
Michigan
- AgelessRx, Ann Arbor
View the official record on ClinicalTrials.gov →
Follow this trial
Get an email when our monthly digest covers enrollment changes and results for trials like this one.